HbA1c Analyzer Market
HbA1c Analyzer Market Study by High-performance Liquid Chromatography (HPLC), Ion Exchange Chromatography, Boronate Affinity Technology, and Boronate Affinity HPLC from 2024 to 2034
Analysis of HbA1c Analyzer Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
HbA1c Analyzer Market Outlook (2024 to 2034)
The need for HbA1c analyzers spurred in the following years with the rise in diabetes incidence throughout the world. In the current year, 2024, the net revenue generated by the sales of HbA1c monitoring devices across the world is estimated to be around US$ 2,165 million. The global HbA1c analyzer market size in 2019 was figured to be around US$ 1,679.7 million.
The survey report by Fact.MR on the global HbA1c testing industry implies that global demand for HbA1c analyzers will surge at a 5.1% CAGR over the next ten years. With rising awareness and health consciousness among general people, the demand for instruments for routine testing for diabetics, as well as for tracking long-term glycemic management, is increasing day by day.
By the end of this forecast period, the global HbA1c testing device market size, in terms of value, is projected to reach up to US$ 3,547.6 million by 2034. As point-of-care testing technologies continue to progress, HbA1c analyzers have become increasingly accessible and user-friendly. It is expected to strengthen the glycated hemoglobin testing industry outlook in the future as well.
HbA1c Analyzer Market Trends and Analysis
- As people's knowledge of the significance of glycemic management has improved in the last few years, so too requires HbA1c analyzers.
- Modern diabetes management tools have empowered both individuals and medical professionals to manage diabetes wisely.
- Widespread adoption of hemoglobin A1c measurement devices in a variety of healthcare settings is propelling the sales of the HbA1c analyzer market.
- Healthcare policies emphasize the early identification and prevention of diabetes-related issues.
- Easy integration of data obtained from HbA1c analyzers with electronic health records makes the product popular among medical professionals.
|Estimated Market Value (2024E)
|US$ 2,165 million
|Forecasted Market Value (2034F)
|US$ 3,547.6 million
|Global Market Growth Rate (2024 to 2034)
|Reagents and Consumables Segment Growth Rate (2024 to 2034)
|Diagnostic Centers Segment Growth Rate (2024 to 2034)
|North America Market Share (2024)
|Western Europe Market Share (2024)
|Key Companies Profiled
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the Key Factors for Hemoglobin A1c Measurement Market Growth?
“Technological Advancements have Strengthened the Diabetes Diagnostic Devices Trends”
In the recent past, there has been a surge in investments in new diabetes diagnostics devices and technologies, which has improved the accuracy and reliability of HbA1c analyzers. Likewise, the smooth integration of HbA1c analyzers with electronic health records enables medical practitioners to access full patient data that helps them make well-informed decisions.
Global programs targeted at improving diabetes management, particularly in areas where diabetes constitutes a substantial public health burden, are also driving the sales of HbA1c analyzers. The demand for mobile or point-of-care HbA1c analyzers has increased at a faster pace due to healthcare policies that emphasize early identification and prevention of diabetes-related problems.
What are the Significant Challenges for Global HbA1c Analyzer Suppliers?
“Stringent and Diverse Regulatory Standards have Limited the Expansion Rate”
Like every other piece of equipment meant for the healthcare sector, the regulatory standards for approval of innovative HbA1c analyzer products or designs are quite rigorous. Moreover, the standards for imported or newly developed HbA1c analyzers vary from country to country. On the other hand, the unavailability of sufficient healthcare infrastructure in many countries limits the use and sales of clinical hemoglobin testing tools and equipment.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
|Regional Market CAGR (2024 to 2034)
Why Germany is Turning into a Lucrative Market for HbA1c Analyzer Manufacturers?
“Greater Control over Europe Healthcare Sector along with Rising Domestic Demand has Strengthened the German Market”
The HbA1c testing market size in all Western European countries together is estimated to be around US$ 503 million in 2024. The demand for dependable and effective HbA1c analyzers to identify and track people at risk has increased in Europe with the introduction of diabetes screening programs at the community and clinical levels. Now, Western Europe commands roughly 23.2% of the global HbA1c laboratory testing market.
Germany is the leading manufacturer and supplier of HbA1c analyzers in Western Europe, with a market valuation of US$ 117 million for the year 2024. In terms of market share, Germany is estimated to contribute to nearly 23.2% of the total demand for HbA1c analyzers in Western Europe in 2024. Moreover, a rise in healthcare spending in the country, notably for the treatment of diabetes, is expected to increase the domestic demand for HbA1c analyzers during the forecast years. According to an industry analysis report by Fact.MR, the HbA1c analyzers industry in Germany, is poised to grow at a rate of 5.5% per year between 2024 and 2034.
The United Kingdom market, with a valuation of US$ 79 million in 2024, follows Germany in the development of its HbA1c testing device industries. This regional market is anticipated to follow a compound annual growth rate of 5.3% through the projection year. The market forecast report by Fact.MR further predicts the United Kingdom market value to reach US$ 132 million by 2034 end.
Why is the United States Dominating the North American HbA1c Analyzer Market?
“The United States is at the Helm of the Global HbA1c Testing Industry Developments”
In 2024, the total sales of HbA1c analyzers by industries located in Canada, Mexico, and the United States are expected to generate a revenue of around US$ 1,075 million. Furthermore, it is figured out to be around 49.7% of the global sales of HbA1c analyzers that are forecast to be achieved this year.
The United States is the most prominent country in North America for the production and supply of HbA1c analyzers. The country currently holds sway over almost 88.6% of the regional market share. In terms of value, the United States HbA1c analyzer market is estimated to be around US$ 952 million in 2024. By the end of this forecast period, the net worth of the industry is forecast to reach around US$ 1,591 million.
The trend toward personalized medication and healthcare in the United States has increased the significance of HbA1c analyzers in adapting diabetes care approaches. Industry players in the United States have also quickly evolved clinical glycated hemoglobin analysis devices in the last few years, allowing medical professionals to customize treatment regimens according to patient requirements.
Canada contributes nearly 7.8% of the North American market share, and the net worth of all HbA1c analyzer industries operating in the country is estimated to be around US$ 84 million in 2024. The regional market for HbA1c analyzers in Canada is expected to progress at a 4.9% CAGR from 2024 to 2034, concluding at a valuation of US$ 136 million.
Why is Boronate Affinity HPCL Technology Preferred for Making an HbA1c Analyzer?
“Rising Craze for Compact and Portable HbA1c Analyzers has Raised the Demand for Boronate Affinity Technology”
In 2024, the sales of HbA1c analyzers made using HPCL technology are estimated to garner a revenue of around US$ 998.8 million. This revenue contribution is estimated to be around 46.1% of the total revenue generated by the HbA1c analyzers market in 2024.
Recently, there has been a substantial increase in the demand for HbA1c analyzers made using boronate affinity high-performance liquid chromatography (HPLC) technology. The growing demand for portable and small diagnostic tools has increased the design of HbA1c analyzers based on boronate affinity HPLC technology. Over the next ten years, the supply of HbA1c analyzers from this technology segment is expected to rise at a higher 5.5% CAGR.
Why Diagnostic Centers Create More Demand for HbA1c Analyzers than Hospitals?
“Convenience of Hemoglobin A1c Measurement at Diagnostic Centers makes it the Leading End User”
Based on different end users of HbA1c analyzers, the diagnostic centers segment is estimated to create 42.1% of the total demand in 2024. The net revenue contributed by this segment is estimated to be around US$ 912 million in 2024.
The demand for HbA1c analyzers in hospitals is less than that in diagnostic centers, as patients find them more convenient and accessible in diagnostic centers. During the forecast period, this segment is projected to expand at a 4.9% CAGR, and its total valuation is forecast to be around US$ 1,475.4 million by 2034.
The expansion and specialization of healthcare services in recent years have been observed to be driving the hospital segment at a faster rate. Between 2024 and 2034, the demand for HbA1c analyzers from all hospitals is predicted to rise at 5.5% CAGR. The forecast report further predicts the total valuation of this market segment to be around US$ 1,197.8 million by 2034.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Leading or established HbA1c analyzer manufacturers help healthcare practitioners make well-informed decisions about managing diabetes by offering precise and consistent findings. This has led to the concentration of the global demand for HbA1c analyzers in the hands of a few renowned industry players or healthcare brand holders. However, the market is slowly but gradually diversifying after the emergence of many new players outside of the United States and Western European countries.
- In 2021, Trivitron Healthcare, a medical equipment supplier, launched NANO H5 and NANO H110, HPLC technology-based diagnostic solutions for HbA1c. The products are used to monitor diabetes and hemoglobin variants.
- In December 2021, ARKRAY, a manufacturer of diabetes testing equipment, launched a high-speed HbA1c analyzer with an aim to target the clinical diagnostic market in the United Kingdom. The analyzer ADAMS A1c HA-8190V can deliver a test result within 24 seconds.
Key Segments Covered by HbA1c Analyzer Industry Survey Report
- High-performance Liquid Chromatography (HPLC)
- Ion Exchange Chromatography
- Boronate Affinity Technology
- Boronate Affinity HPLC
By End User
- Specialty Clinics
- Diagnostic Centers
- North America
- Latin America
- East Asia
- South Asia & Oceania
- The Middle East & Africa (MEA)
- FAQs -
What was the Value of the HbA1c Analyzer Market in 2019?
The global HbA1c analyzer market was worth US$ 1,679.7 million in 2019.
What is the Sales Outlook for HbA1c Analyzer in 2024?
The global HbA1c analyzer market is likely to be valued at US$ 2,165 million in 2024.
What is the Demand Forecast for HbA1c Analyzer for the Decade?
The HbA1c analyzer market value is likely to reach US$ 3,547.6 million by the end of 2034.
What is the Predicted Growth Rate for HbA1c Analyzer Market?
Adoption of HbA1c analyzer is projected to rise at a CAGR of 5.1% through 2034.
At What Rate is the Market in North America predicted to grow?
The United States HbA1c analyzer market is likely to register a CAGR of 5.3% through 2034.